682 related articles for article (PubMed ID: 30066406)
1. Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.
Furtado D; Björnmalm M; Ayton S; Bush AI; Kempe K; Caruso F
Adv Mater; 2018 Nov; 30(46):e1801362. PubMed ID: 30066406
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
[TBL] [Abstract][Full Text] [Related]
3. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy.
Xi Y; Chen Y; Jin Y; Han G; Song M; Song T; Shi Y; Tao L; Huang Z; Zhou J; Ding Y; Zhang H
J Control Release; 2022 May; 345():38-61. PubMed ID: 35257810
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
5. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.
Zha S; Liu H; Li H; Li H; Wong KL; All AH
ACS Nano; 2024 Jan; 18(3):1820-1845. PubMed ID: 38193927
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterial applications in multiple sclerosis inflamed brain.
Ballerini C; Baldi G; Aldinucci A; Maggi P
J Neuroimmune Pharmacol; 2015 Mar; 10(1):1-13. PubMed ID: 25616566
[TBL] [Abstract][Full Text] [Related]
7. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X
Small; 2017 Nov; 13(43):. PubMed ID: 29045030
[TBL] [Abstract][Full Text] [Related]
8. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
9. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
Song J; Lu C; Leszek J; Zhang J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
[TBL] [Abstract][Full Text] [Related]
10. Targeting central nervous system pathologies with nanomedicines.
Mizrahy S; Gutkin A; Decuzzi P; Peer D
J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
[TBL] [Abstract][Full Text] [Related]
11. Theranostical application of nanomedicine for treating central nervous system disorders.
Ran W; Xue X
Sci China Life Sci; 2018 Apr; 61(4):392-399. PubMed ID: 29675554
[TBL] [Abstract][Full Text] [Related]
12. Approaches for encephalic drug delivery using nanomaterials: The current status.
V A; Cutinho LI; Mourya P; Maxwell A; Thomas G; Rajput BS
Brain Res Bull; 2020 Feb; 155():184-190. PubMed ID: 31790722
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in nanomaterials for neural applications: opportunities and challenges.
Sisubalan N; Shalini R; Ramya S; Sivamaruthi BS; Chaiyasut C
Nanomedicine (Lond); 2023 Nov; 18(26):1979-1994. PubMed ID: 38078433
[TBL] [Abstract][Full Text] [Related]
14. Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain.
Wu JR; Hernandez Y; Miyasaki KF; Kwon EJ
Adv Drug Deliv Rev; 2023 Jun; 197():114820. PubMed ID: 37054953
[TBL] [Abstract][Full Text] [Related]
15. Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Colloids Surf B Biointerfaces; 2023 Jan; 221():112999. PubMed ID: 36368148
[TBL] [Abstract][Full Text] [Related]
16. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration.
Bahadur S; Prakash A
Curr Drug Targets; 2023; 24(1):71-88. PubMed ID: 36278468
[TBL] [Abstract][Full Text] [Related]
19. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
20. Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers.
Singh AV; Chandrasekar V; Janapareddy P; Mathews DE; Laux P; Luch A; Yang Y; Garcia-Canibano B; Balakrishnan S; Abinahed J; Al Ansari A; Dakua SP
ACS Chem Neurosci; 2021 Jun; 12(11):1835-1853. PubMed ID: 34008957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
